AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Innoviva, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SF23V0
20.66▼ 0.40 (-1.90%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
21.06
Day's Range
20.51 – 20.94
52-Week Range
17.45 – 25.15
Volume
978.5K
Avg Volume
813.0K
Share Statistics
Shares Outstanding
Employees
159
Exchange
XNAS
Listed
2004-10-05
Share count as of July 31, 2026

Innoviva, Inc. Common Stock (INVA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Innoviva, Inc. Common Stock (INVA)
What is Innoviva, Inc. Common Stock's Market Cap?
Innoviva, Inc. Common Stock's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's Enterprise Value?
Innoviva, Inc. Common Stock's Enterprise Value is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's Trailing P/E?
Innoviva, Inc. Common Stock's Trailing P/E is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's Price / Sales?
Innoviva, Inc. Common Stock's Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's EV / Revenue?
Innoviva, Inc. Common Stock's EV / Revenue is 2.7×, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's EV / EBITDA?
Innoviva, Inc. Common Stock's EV / EBITDA is 6.2×, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's Revenue (TTM)?
Innoviva, Inc. Common Stock's Revenue (TTM) is $440.0M, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's Net Income (TTM)?
Innoviva, Inc. Common Stock's Net Income (TTM) is $357.2M, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's EBITDA?
Innoviva, Inc. Common Stock's EBITDA is $189.0M, based on as-reported figures from SEC (XBRL) filings.
What is Innoviva, Inc. Common Stock's Diluted EPS (TTM)?
Innoviva, Inc. Common Stock's Diluted EPS (TTM) is 4.94, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · INVAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth+19.3%+10.6%+24.8%+20.4%
Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding amortization of intangible assets)
Amortization of acquired intangible assets
Gross profit
% of revenue75.8%77.4%66.0%70.1%
Operating expenses:
Selling, general and administrative
Research and development
Total operating expenses
% of revenue33.2%38.5%32.0%38.0%
Income from operations
% of revenue42.5%38.9%34.0%32.1%
Changes in fair values of equity method investments, net
Changes in fair values of equity and long-term investments, net
Interest and dividend income
Interest expense
Other expense, net
Income (loss) before income taxes
Income tax benefit (expense), net
Net income (loss) and comprehensive income (loss)
% of revenue-69.8%190.4%143.2%83.4%
Basic—
Diluted—